SNPs in PI3K-PTEN-mTOR and brain metastases in NSCLC--response

Affiliations

¹ Authors' Affiliation: Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.
² Authors' Affiliation: Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China yxl@medmail.com.cn.

Comment

Qianxia Li et al. Clin Cancer Res. 2014.

. 2014 Jul 1;20(13):3625-6.

doi: 10.1158/1078-0432.CCR-14-0206. Epub 2014 May 6.

¹ Authors' Affiliation: Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.
² Authors' Affiliation: Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China yxl@medmail.com.cn.

No abstract available

Comment on

Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer.
Li Q, Yang J, Yu Q, Wu H, Liu B, Xiong H, Hu G, Zhao J, Yuan X, Liao Z. Li Q, et al. Clin Cancer Res. 2013 Nov 15;19(22):6252-60. doi: 10.1158/1078-0432.CCR-13-1093. Epub 2013 Sep 27. Clin Cancer Res. 2013. PMID: 24077347
SNPs in PI3K-PTEN-mTOR and brain metastases in NSCLC--letter.
Avan A, Maftouh M, Avan A, Tibaldi C, Zucali PA, Giovannetti E. Avan A, et al. Clin Cancer Res. 2014 Jul 1;20(13):3623-4. doi: 10.1158/1078-0432.CCR-13-3256. Epub 2014 May 6. Clin Cancer Res. 2014. PMID: 24803580 No abstract available.